Return to Programs

Technical program



April, 22nd Pasteur Amphitheater Lounge Lunch area Outside
08:10 – 08:20  David Guiraud, Nigel Lovell
08:20 – 09 :30   Poster session/coffee break
09:30 – 11:00 Oral session Poster session  
11:00 – 11:45 Plenary: Hugues Duffau      
11:45 – 12:45     Lunch  
12:45 – 13:30 Plenary: Warren M. Grill
13:30 – 15:00 Invited session: Visual prosthetics* Poster session  
15:00 – 16:00   Poster session/coffee break
16:00 – 17:30 Symposium: BCI
 19:00 – 23:00
                          Gala Dinner – Grant Ceremony


April, 23rd Pasteur Amphitheater Lounge Lunch area Outside
08:00 – 09 :30 Symposium: BMI control of FES    
09:30 – 10 :00   Coffee break  
10 :00 – 11:30 Oral session      
11:30 – 12:15 Plenary: Karlheinz Meier      
12:15 – 13:15       Poster
13:15 – 14:45 Oral Session Poster session  
14:45 – 15:15   Poster session/coffee break
15:15 – 16:15 Invited Session: Organic Electronics
16:30 – 18:00 Symposium: Autonomic visceral modulation


April, 24th Pasteur Amphitheater Lounge Lunch area Outside
08:00 – 09:30   Poster session/coffee break
09:30 – 11:00 Oral session Poster session  
11:00 – 11:45 Plenary: John Rogers      
11:45 – 12:45     Lunch  
12:45 – 14:15 Invited session: Neurophotonics* Poster session  
14:15 – 15:15   Poster session/coffee break
15:15 – 16:45 Symposium: Neuromodulation for epilepsy    
16:45 – 17:00 David Guiraud, Nigel Lovell

Rapidly emerging optical and genetic approaches are changing our understanding of how information is coded by the brain. Assuming that they can be implemented safely, these approaches show great promise in clinical neurophysiology, enabling devices that can communicate with specific cell types in the nervous system. This invited session will focus on new genetic and optical technologies that allow interaction with large numbers of individual cells in real time.
Chairpersons: J. A. White, S. Shoham
*Visual prosthetics
The last few years has seen dramatic improvement in the field of artificial vision. For example, both Second Sight (USA) and Retina Implant (Germany) received regulatory approval to begin sales of their retinal prosthetic devices. During this same period, two additional companies, Pixium (France) and Bionic Vision (Australia), have begun clinical trials with their new devices as well. Despite this progress however, considerable challenges – especially in the ability to elicit high quality vision consistently. The session proposed here will focus on recent progress as well as on strategies to overcome existing challenges. Speakers from Second Sight, Retina Implant and Bionic Vision Australia have all committed to giving a talk. In addition, Frank Lane, from Illinois Institute of Technology has confirmed as well. Frank has been interviewing the users of the original Dobelle implant; his findings are fascinating and directly relevant to this effort. Thus representatives from all major clinical efforts will be represented.
Chairpersons : Shelley Fried, Gaëlle Lissorgues
*Soft and organic bioelectronics
A visible trend over the past few years involves the application of organic electronic devices to neural interface devices. Organic devices offer several distinct advantages compared to incumbent technologies, including mechanical flexibility, tunability of their structure via chemical synthesis, enhanced biocompatibility, and capability of drug delivery. Most importantly, high ionic mobilities in organic semiconductors enable new modes of interfacing between neurons and electronics. As such, organics promise to yield new tools for neuroscience and enhance our understanding on how the brain works. This invited session includes invited talks from experts who will showcase the different research directions in this exciting field.
Chairpersons: George Malliaras, Stéphanie Lacour

Permanent link to this article: